Human Genome Epidemiology Literature Finder
Records 1 - 15 (of 15 Records) |
Query Trace: Thrombosis and CYP3A4[original query] |
---|
Impact of CYP2C19 polymorphisms on the antiplatelet effect of clopidogrel in an actual clinical setting in Japan. Circulation journal : official journal of the Japanese Circulation Society 2009 Jun . Jinnai T, Horiuchi H, Makiyama T, Tazaki J, Tada T, Akao M, Ono K, Hoshino K, Naruse Y, Takahashi K, Watanabe H, Kita T, Kimura T |
Perioperative genomic profiles using structure-specific oligonucleotide probes. Clinical medicine & research 2009 Sep 7 (3): 69-84. Hogan Kirk J, Burmester James K, Caldwell Michael D, Hogan Quinn H, Coursin Douglas B, Green Dawn N, Selzer Rebecca M R, Broderick Thomas P, Rusy Deborah A, Poroli Mark, Lutz Anna L, Sanders Allison M, Oldenburg Mary C, Koelbl James A, de Arruda-Indig Monika, Halsey Jennifer L, Day Stephen P, Domanico Michael |
CYP2C19*2 and CYP2C9*3 alleles are associated with stent thrombosis: a case-control study. European heart journal 2010 Dec 31 (24): 3046-53. Harmsze Ankie M, van Werkum Jochem W, Ten Berg Jurriën M, Zwart Bastiaan, Bouman Heleen J, Breet Nicoline J, van 't Hof Arnoud W J, Ruven Hendrik J T, Hackeng Christian M, Klungel Olaf H, de Boer Anthonius, Deneer Vera H |
Amlodipine, clopidogrel and CYP3A5 genetic variability: effects on platelet reactivity and clinical outcomes after percutaneous coronary intervention. Heart (British Cardiac Society) 2012 Sep 98 (18): 1366-72. Park Kyung Woo, Kang Jeehoon, Park Jin Joo, Yang Han-Mo, Lee Hae-Young, Kang Hyun-Jae, Koo Bon-Kwon, Oh Byung-Hee, Park Young-Bae, Kim Hyo-S |
The impact of gene polymorphism and high on-treatment platelet reactivity on clinical follow-up: outcomes in patients with acute coronary syndrome after drug-eluting stent implantation. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2013 Jul 9 (3): 316-27. Liang Zhen-Yang, Han Ya-Ling, Zhang Xiao-Lin, Li Yi, Yan Cheng-Hui, Kang Ji |
Routine assessment of on-clopidogrel platelet reactivity and gene polymorphisms in predicting clinical outcome following drug-eluting stent implantation in patients with stable coronary artery disease. JACC. Cardiovascular interventions 2013 Nov 6 (11): 11. Viviani Anselmi C, Briguori C, Roncarati R, Papa L, Visconti G, Focaccio A, De Micco F, Latronico MV, Pagnotta P, Condorelli G |
Gene polymorphism of CYP2C19*2, *3 and CYP3A4*1B and early stent thrombosis: case reports and literature review. Personalized medicine 2016 Sep 13 (5): 423-428. Kulmyrzaeva Nazgul, Tatarunas Vacis, Skipskis Vilius, Smagulova Gaziza, Seitmaganbetova Nazgul, Veikutiene Audrone, Lesauskaite Vai |
Associations of CYP3A4, NR1I2, CYP2C19 and P2RY12 polymorphisms with clopidogrel resistance in Chinese patients with ischemic stroke. Acta pharmacologica Sinica 2016 May . Liu Rui, Zhou Zi-Yi, Chen Yi-Bei, Li Jia-Li, Yu Wei-Bang, Chen Xin-Meng, Zhao Min, Zhao Yuan-Qi, Cai Ye-Feng, Jin Jing, Huang M |
Cytochrome allelic variants and clopidogrel metabolism in cardiovascular diseases therapy. Molecular biology reports 2016 Apr . Jarrar Mohammed, Behl Shalini, Manyam Ganiraju, Ganah Hany, Nazir Mohammed, Nasab Reem, Moustafa Khal |
Interindividual variability in dabigatran and rivaroxaban exposure: contribution of ABCB1 genetic polymorphisms and interaction with clarithromycin. Journal of thrombosis and haemostasis : JTH 2016 Nov . Gouin-Thibault I, Delavenne X, Blanchard A, Siguret V, Salem J E, Narjoz C, Gaussem P, Beaune P, Funck-Brentano C, Azizi M, Mismetti P, Loriot M |
Do CYP2C19 and ABCB1 gene polymorphisms and low CYP3A4 isoenzyme activity have an impact on stent implantation complications in acute coronary syndrome patients? Pharmacogenomics and personalized medicine 2017 10 10 243-245. Rytkin Eric, Mirzaev Karin B, Grishina Elena A, Smirnov Valeriy V, Ryzhikova Kristina A, Sozaeva Zhannet A, Giliarov Michael Iu, Andreev Denis A, Sychev Dmitriy |
The CYP2C19*2 and CYP2C19*17 Polymorphisms play a Vital Role in Clopidogrel Responsiveness after Percutaneous Coronary Intervention: A Pharmacogenomics Study. Basic & clinical pharmacology & toxicology 2017 Jan . Saydam Faruk, De?irmenci ?rfan, Birdane Alparslan, Özdemir Mahmut, Ulus Taner, Özbayer Cansu, Çolak Ertu?rul, Ata Necmi, Güne? Hasan Vey |
Clopidogrel Pharmacogenetics in Iranian Patients Undergoing Percutaneous Coronary Intervention. Cardiovascular toxicology 2018 May . Mahdieh Nejat, Rabbani Ahmad, Firouzi Ata, Zahedmehr Ali, Hoseinimoghaddam Maryam, Saedi Sedigheh, Sanati Hamidreza, Basiri Hosseinali, Noohi Feridoun, Rabbani Bahareh, Maleki Maj |
Profiling of warfarin pharmacokinetics-associated genetic variants: Black Africans portray unique genetic markers important for an African specific warfarin pharmacogenetics-dosing algorithm. Journal of thrombosis and haemostasis : JTH 2021 Aug . Ndadza Arinao, Muyambo Sarudzai, Mntla Pindile, Wonkam Ambroise, Chimusa Emile, Kengne Andre P, Ntsekhe Mpiko, Dandara Coll |
Effects of CYP3A4*22 and CYP3A5 on clinical outcome in patients treated with ticagrelor for ST-segment elevation myocardial infarction: POPular Genetics sub-study. Frontiers in pharmacology 2022 12 13 1032995. Azzahhafi Jaouad, Bergmeijer Thomas O, van den Broek Wout W A, Chan Pin Yin Dean R P P, Rayhi Senna, Peper Joyce, Bor Willem L, Claassens Daniel M F, van Schaik Ron H N, Ten Berg Jurriën |
- Page last reviewed:Oct 1, 2023
- Page last updated:Dec 04, 2023
- Content source: